News

Exclusive: US FDA asks some fired pharma user fee negotiation staff to return
The U.S. Food and Drug Administration is asking some of its recently fired staff responsible for critically important funding ...
US FDA accepts Novo Nordisk's application for oral Wegovy for weight loss
The U.S. Food and Drug Administration has accepted Novo Nordisk's marketing application for an oral version of its ...
Neuralink's speech restoration device gets FDA's 'breakthrough' tag
Neuralink has received the U.S. Food and Drug Administration's "breakthrough" tag for its device to restore communication for ...
US FDA approves J&J's immune disorder drug
The U.S. Food and Drug Administration on Wednesday approved Johnson & Johnson's drug to treat a type of muscle-weakening ...
FDA delays decision on Stealth BioTherapeutics' rare genetic disorder drug
The U.S. Food and Drug Administration has delayed its decision on marketing approval for Stealth BioTherapeutics' treatment ...
US FDA suspends milk quality tests amid workforce cuts
The Food and Drug Administration is suspending a quality control program for testing of fluid milk and other dairy products ...
UK's Genus secures FDA approval for PRP gene edit; shares soar
British animal genetics company Genus on Wednesday said the U.S. Food and Drug Administration (FDA) approved its PRP gene ...
South Africa's Rabada admits to failing drug test
South Africa fast bowler Kagiso Rabada, who returned home from the Indian Premier League last month, admitted failing a drug ...
Exclusive: FDA fires most negotiators for pharma user fee talks, sources say
The U.S. Food and Drug Administration's mass layoffs included senior negotiators in talks with the pharmaceutical industry ...
Trump confirms he offered to send US troops to Mexico to help with cartels
U.S. President Donald Trump on Sunday confirmed he had offered to send U.S. troops to Mexico to help Mexican President Claudia Sheinbaum combat drug trafficking, an offer Sheinbaum disclosed on ...
Novartis to buy kidney disease drug maker Regulus in up to $1.7 billion deal
Novartis has agreed to buy Regulus Therapeutics for up to $1.7 billion, giving the Swiss drugmaker access to an experimental ...
US FDA chief says firings won't hinder agency's target dates for drug reviews
The U.S. Food and Drug Administration will meet its targets for completing reviews of new drugs despite mass firings at the agency under the Trump administration, its chief said.